trade-ideas

Investors Can Soon Take Amgen in Larger Doses

The pharma giant has more strength in its uptrend and is poised to make new highs, so here's how to play it.

Jun 25, 2024, 9:42 AM EDT

You've reached your free article limit

You've read 0 of 1 free Pro articles.

Unlock unlimited Pro access — 50% off
Already registered or a Pro member? Log in

In my May 3 update on Amgen AMGN, I wrote that "The question that needs an answer is where do I recommend purchase of AMGN. I am not sure of a level but investors could probe the long side of AMGN after a few days of sideways price action. Maybe we'll see support in the $305 area as some traders take profits."

Traders got a pullback in price to buy and now prices are ready for an upside breakout.

Let's check the charts.

In this daily bar chart of AMGN, below, I can see that prices have hit resistance in the $320-$330 area a number of times since early February. Prices trade above the rising 50-day moving average line and above the rising 200-day moving average line. Trading volume has been more active since February. The On-Balance-Volume (OBV) line shows some tentative improvement since a low in March. The Moving Average Convergence Divergence (MACD) oscillator is above the zero-line and crossing to the upside for a fresh outright buy signal.

In this weekly Japanese candlestick chart of AMGN, below, I can see a positive picture. Prices are in a longer-term uptrend and trade above the rising 40-week moving average line. The weekly OBV line has a positive trend and the MACD oscillator is above the zero-line.

In this daily Point and Figure chart of AMGN, below, I can see a price target in the $435 area. A trade at $327.97 will refresh the uptrend.

In this weekly Point and Figure chart of AMGN, below, I can see the same $435 price target as shown in the daily chart above.

Bottom line strategy: Traders should continue to hold long positions in AMGN. Add to longs on strength above $328. The round number of $400 area is my first price target for now.

Employees of TheStreet are prohibited from trading individual securities.